Arrowgrass Capital Partners (US)’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-45,300
Closed -$525K 216
2019
Q2
$525K Sell
45,300
-4,700
-9% -$54.5K 0.01% 215
2019
Q1
$725K Buy
+50,000
New +$725K 0.02% 185